tiprankstipranks
Trending News
More News >
Eli Lilly & Co (LLY)
NYSE:LLY
US Market

Eli Lilly & Co (LLY) Income Statement

Compare
20,395 Followers

Eli Lilly & Co Income Statement

Last quarter (Q3 2025), Eli Lilly & Co's total revenue was $17.60B, an increase of 53.87% from the same quarter last year. In Q3, Eli Lilly & Co's net income was $5.58B. See Eli Lilly & Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 45.04B$ 34.12B$ 28.54B$ 28.32B$ 24.54B
Gross Profit
$ 36.62B$ 27.04B$ 21.91B$ 21.01B$ 19.06B
Operating Expenses
$ 19.12B$ 16.25B$ 13.26B$ 13.07B$ 11.85B
Depreciation and Amortization
$ 1.77B$ 1.53B$ 1.52B$ 1.55B$ 1.32B
EBITDA
$ 15.23B$ 8.57B$ 8.66B$ 8.04B$ 8.91B
Operating Income
$ 17.50B$ 10.79B$ 8.65B$ 7.93B$ 7.21B
Other Income/Expenses
$ -4.82B$ -4.23B$ -1.85B$ -1.78B$ 19.10M
Pretax Income
$ 12.68B$ 6.55B$ 6.81B$ 6.16B$ 7.23B
Net Income
$ 10.59B$ 5.24B$ 6.24B$ 5.58B$ 6.19B
Per Share Metrics
Basic EPS
$ 11.76$ 5.83$ 6.57$ 5.85$ 6.47
Diluted EPS
$ 11.71$ 5.80$ 6.57$ 5.85$ 6.47
Weighted Average Shares Outstanding
900.61M 899.38M 950.18M 953.65M 956.59M
Weighted Average Shares Outstanding (Diluted)
904.06M 903.28M 950.18M 953.65M 956.59M
Currency in USD

Eli Lilly & Co Earnings and Revenue History